New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 11, 2014
15:32 EDTFST, REN, TWER, CZR, GSAT, OPK, NUAN, TRAK, CIM, RAX, VTR, JOBS, MR, ICPTNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Ventas (VTR), consensus $1.09; Nuance Communications (NUAN), consensus 27c; Intercept Pharmaceuticals (ICPT), consensus (12c); Rackspace Hosting (RAX), consensus 16c; Opko Health (OPK), consensus (9c); Mindray Medical (MR), consensus 54c; Chimera Investment (CIM), consensus 9c; Globalstar (GSAT), one estimate (4c); 51job (JOBS), consensus 32c; Dealertrack Technologies (TRAK), consensus 373c; Caesars Entertainment (CZR), consensus ($1.19); Towerstream (TWER), consensus (10c); Resolute Energy (REN), consensus 1c; Forest Oil (FST), consensus (2c).
News For VTR;NUAN;ICPT;RAX;OPK;MR;CIM;GSAT;JOBS;TRAK;CZR;TWER;REN;FST From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
March 2, 2015
16:17 EDTGSATGlobalstar reports Q4 EPS 8c, one estimate (3c)
Subscribe for More Information
16:11 EDTCZRCaesar's drops after hours following earnings
Shares have given back the gains of the regular session following earnings, last down over 4.2% to $10.55. At that price next support is at $10.09.
16:03 EDTCZRCaesar's reports Q4 EPS ($7.00), may not compare to consensus ($1.65)
Subscribe for More Information
15:23 EDTCZRNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Mylan (MYL), consensus $1.05... Nabors Industries (NBR), consensus 39c... PRA Group (PRAA), consensus $1.11... Caesars Entertainment (CZR), consensus ($1.65)... Cumulus Media (CMLS), consensus 9c... Arena Pharmaceuticals (ARNA), consensus (12c)... Palo Alto Networks (PANW), consensus 17c... Guidewire Software (GWRE), consensus 11c... McDermott International (MDR), consensus (6c)... Salix Pharmaceuticals (SLXP), consensus (25c)... Matador Resources (MTDR), consensus 19c... Sanchez Energy (SN), consensus (11c).
11:52 EDTOPKOPKO Health price target raised to $18.50 from $14.50 at Ladenburg
Subscribe for More Information
10:02 EDTGSATHigh option volume stocks
High option volume stocks: MNTA NTRI KOS NST GSAT THC CHL MSI CAKE NXPI
06:13 EDTICPTIntercept reports Q4 EPS ($1.63), consensus ($1.67)
Subscribe for More Information
February 27, 2015
17:36 EDTOPKOPKO Health says has adequate liquidity to continue product development
The company said, "We believe that OPKO’s cash and cash equivalents of $96.9 million at December 31, 2014, together with the $295.0 million in upfront payments from Pfizer received in 2015, provide OPKO with adequate liquidity to continue development of its product candidates."
17:33 EDTOPKOPKO Health reports Q4 EPS (12c), consensus (6c)
Subscribe for More Information
09:35 EDTCZRNevada reports January statewide gaming win up 7.75% to $952.7M
Subscribe for More Information
February 25, 2015
14:07 EDTCZRCaesar's April calls active into Q4 and outlook
Caesar's April 13 calls are active on total volume of 11K contracts compares to its open interest of zero contracts according to Track Data. Active call volume suggests traders taking positions into the expected release of Q4 results on March 2.
February 24, 2015
10:08 EDTRAXOptions with decreasing implied volatility
Subscribe for More Information
February 23, 2015
18:02 EDTTRAKOn The Fly: After Hours Movers
Subscribe for More Information
16:12 EDTTRAKDealerTrack sees FY15 EPS $1.39-$1.48 , may not compare to consensus $1.82
Sees FY15 revenue $1.08B-$1.1B, consensus $1.02B.
16:08 EDTTRAKDealerTrack reports Q4 EPS 42c, consensus 42c
Subscribe for More Information
10:17 EDTRAXOptions with decreasing implied volatility
Subscribe for More Information
February 20, 2015
12:41 EDTOPKOPKO Health annouces publication of 20 year outcome study for prostate cancer
OPKO Health announced the online publication of a study entitled “Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study” in the journal European Urology. The study shows that the four kallikrein panel of biomarkers utilized in the OPKO 4Kscore Test accurately identify men more likely to develop distant prostate cancer metastases, and men with a low 4Kscore were shown to have a low risk of developing metastatic prostate cancer in a 20-year follow up period. The study is part of the Västerbotten Intervention Project, which was initiated in 1986 in Västerbotten County, Sweden, and is a population-based study involving a health exam at ages 40, 50, and 60 years of age, where blood was drawn and preserved. The VIP study included data on over 40,000 men, representing greater than 57% of the total background population in Västerbotten County. From this cohort, blood samples of men who developed metastatic prostate cancer and age-matched controls of cancer free men were tested for the four kallikreins and their 4Kscore result was determined.
10:30 EDTRAXOptions with decreasing implied volatility
Subscribe for More Information
06:21 EDTTRAKDealerTrack coverage resumed with a Buy at Evercore ISI
Subscribe for More Information
February 19, 2015
16:31 EDTICPTIntercept promotes Lisa Bright to Chief Commercial & Corporate Affairs Officer
Intercept Pharmaceuticals announced that Lisa Bright has been promoted to the newly-created position of Chief Commercial and Corporate Affairs Officer. Bright joined Intercept last year from Gilead Sciences where her leadership of the European launch of Sovaldi for the treatment of chronic hepatitis C contributed to the most successful product launch in pharmaceutical history.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use